Catalyst Wire Dossier Catalyst Wire Dossier

MYREPTIC-N

· Chong Kun Dang Pharmaceutical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MYREPTIC-N, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients [Phase 4]

See pricing